154 related articles for article (PubMed ID: 38545797)
1. Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study.
van Boemmel-Wegmann S; Altman KW; Herrera R; Pires PV; Pichardo PFA; Vora P
Sci Prog; 2024; 107(1):368504241238080. PubMed ID: 38545797
[No Abstract] [Full Text] [Related]
2. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
[TBL] [Abstract][Full Text] [Related]
3. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and drug utilisation patterns in patients with chronic cough: a retrospective cohort study using a Japanese claims database.
Arai Y; Okuyama K; Onishi Y; Schelfhout J; Tokita S; Kubo T
BMC Pulm Med; 2022 Nov; 22(1):429. PubMed ID: 36411418
[TBL] [Abstract][Full Text] [Related]
7. Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?
Holden SE; Morice A; Birring SS; Jenkins-Jones S; Langerman H; Weaver J; Currie CJ
Curr Med Res Opin; 2020 Jan; 36(1):139-150. PubMed ID: 31558053
[No Abstract] [Full Text] [Related]
8. A register-based study: cough - a frequent phenomenon in the adult population.
Backer V; Porsborg A; Hansen V; Skjold T; Schmid JM; Kehlet M; Torp-Pedersen C; Aasbjerg K
BMC Pulm Med; 2022 Nov; 22(1):426. PubMed ID: 36401236
[TBL] [Abstract][Full Text] [Related]
9. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study.
Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
Ther Adv Respir Dis; 2023; 17():17534666231167716. PubMed ID: 37078383
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a mixed-method study to assess chronic cough in patients with renal cell carcinoma: the prevalence, impact on quality of life, trigger and potential clinical application of chronic cough as an early screening tool in patients with kidney cancer.
Smith W; Loizidou M; Mazzone S; Mumtaz F; Gurusamy K; Ranieri V; Tran MG
BMJ Open; 2023 Nov; 13(11):e074077. PubMed ID: 37949629
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
12. Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
MacLean E; Cisar L; Mehle K; Eremina D; Quigley JM
J Manag Care Spec Pharm; 2016 Jun; 22(6):723-732u. PubMed ID: 27231799
[TBL] [Abstract][Full Text] [Related]
13. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.
Paik JM; Patorno E; Zhuo M; Bessette LG; York C; Gautam N; Kim DH; Kim SC
Pharmacoepidemiol Drug Saf; 2022 Apr; 31(4):467-475. PubMed ID: 34908211
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.
Dong R; Xu X; Yu L; Ding H; Pan J; Yu Y; Shi C; Chen Q; Zhang M; Lv H; Qiu Z
Aliment Pharmacol Ther; 2019 Mar; 49(6):714-722. PubMed ID: 30740748
[TBL] [Abstract][Full Text] [Related]
17. Persistence and compliance with pazopanib in patients with advanced renal cell carcinoma within a U.S. administrative claims database.
Hackshaw MD; Nagar SP; Parks DC; Miller LA
J Manag Care Spec Pharm; 2014 Jun; 20(6):603-10. PubMed ID: 24856598
[TBL] [Abstract][Full Text] [Related]
18. Burden of Specialist-Diagnosed Chronic Cough in Adults.
Zeiger RS; Schatz M; Butler RK; Weaver JP; Bali V; Chen W
J Allergy Clin Immunol Pract; 2020 May; 8(5):1645-1657.e7. PubMed ID: 32059869
[TBL] [Abstract][Full Text] [Related]
19. Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma.
Okubo Y; Yonese J; Kawakami S; Yamamoto S; Komai Y; Takeshita H; Ishikawa Y; Fukui I
Int J Urol; 2007 Sep; 14(9):854-5. PubMed ID: 17760755
[TBL] [Abstract][Full Text] [Related]
20. Persistence and compliance among U.S. patients receiving pazopanib or sunitinib as first-line therapy for advanced renal cell carcinoma: a retrospective claims analysis.
Byfield SA; McPheeters JT; Burton TM; Nagar SP; Hackshaw MD
J Manag Care Spec Pharm; 2015 Jun; 21(6):515-22. PubMed ID: 26011553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
